文献速递脑血管病

确定颅外-颅内搭桥手术的最佳年龄:CMOSS随机试验的事后分析

Determining the Optimal Age for Extracranial-Intracranial Bypass Surgery: A Post Hoc Analysis of the CMOSS Randomized Trial.
PubMed 文献 · Stroke · 2024-12-27

该研究是对CMOSS随机试验的事后分析,纳入324例症状性颈内动脉或大脑中动脉闭塞伴血流动力学不足患者,随机分为搭桥手术联合药物治疗组(n=161)和单纯药物治疗组(n=163)。结果显示,年龄切点55.5岁可预测手术组主要结局,年轻组(≤55.5岁)手术较单纯药物降低主要结局风险(3.2% vs 11.6%;HR 0.255,95%CI 0.071-0.916;P=0.036),而年长组(>55.5岁)无显著差异。

要点

  • 年龄切点55.5岁可预测搭桥手术组主要结局(AUC 0.649,95%CI 0.530-0.769)。
  • 年轻组(≤55.5岁)搭桥手术较单纯药物降低主要结局风险(HR 0.255,95%CI 0.071-0.916;P=0.036)。
  • 年长组(>55.5岁)搭桥手术与单纯药物主要结局无显著差异(HR 0.597,95%CI 0.225-1.580;P=0.298)。

核心结论

  • 在55.5岁及以下伴有症状性颈内动脉或大脑中动脉粥样硬化性闭塞及血流动力学不足的患者中,在药物治疗基础上加用颅外-颅内搭桥手术显著改善了预后。
  • 这些发现提示颅外-颅内搭桥手术的临床应用需要更多研究,以探索纳入更多临床特征的精细化患者选择标准。

研究设计与样本

  • CMOSS(颈动脉或大脑中动脉闭塞手术研究)的事后分析,该试验为随机、开放标签、结局评估者盲法试验,在中国13个中心于2013年6月至2018年3月进行。
  • 共324例因血流动力学不足导致短暂性脑缺血发作或非致残性缺血性卒中的颈内动脉或大脑中动脉闭塞患者,随机分为手术组(n=161,接受颅外-颅内搭桥手术联合药物治疗)和药物组(n=163,仅接受抗血小板治疗和卒中危险因素控制)。
  • 主要结局为随机化后30天内卒中或死亡或30天后至2年同侧缺血性卒中的复合终点。
  • 采用受试者工作特征曲线探索最佳年龄边界,并使用生存分析探索组间差异。

主要发现

  • 在324例患者中(中位年龄52.7岁;男性79.3%),年龄切点55.5岁可预测手术组的主要结局(曲线下面积0.649,95%CI 0.530-0.769)。
  • 患者进一步分为年长组(>55.5岁)和年轻组(≤55.5岁);接受搭桥手术的年轻患者主要结局风险低于年长患者(log-rank P=0.001)。
  • 在年轻组中,接受颅外-颅内搭桥手术的患者主要结局风险低于单纯药物治疗患者(3.2% vs 11.6%;风险比0.255,95%CI 0.071-0.916;P=0.036)。
  • 在年长组中,搭桥手术与单纯药物治疗的主要结局风险无显著差异(17.5% vs 13.3%;校正风险比0.597,95%CI 0.225-1.580;P=0.298)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous trials have failed to demonstrate the benefits of extracranial-intracranial (EC-IC) bypass surgery for patients with carotid or middle cerebral artery occlusion. However, little evidence has focused on the effect of age on prognosis. This study aimed to explore whether EC-IC bypass surgery can provide greater benefits than medical therapy alone in specific age groups. METHODS: A post hoc analysis was performed of the CMOSS (Carotid or Middle Cerebral Artery Occlusion Surgery Study), which was a randomized, open-label, outcome assessor-blinded trial conducted at 13 centers in China between June 2013 and March 2018. A total of 324 patients with internal carotid artery or middle cerebral artery occlusion with transient ischemic attack or nondisabling ischemic stroke attributed to hemodynamic insufficiency were randomized into a surgical group (n=161) that underwent EC-IC bypass surgery with medical therapy, and a medical group (n=163) that received antiplatelet therapy and stroke risk factor control alone. The primary outcome was a composite of stroke or death within 30 days or ipsilateral ischemic stroke beyond 30 days up to 2 years after randomization. Receiver operating characteristic curves were drawn to explore the optimal age boundary, and survival analyses were used to explore differences between groups. RESULTS: Among the 324 patients (median age, 52.7 years; 79.3% men), an age cutoff of 55.5 years predicted the primary outcome in the surgical group (area under the curve, 0.649 [95% CI, 0.530-0.769]). Patients were further divided into an older group (>55.5 years) and a younger group (≤55.5 years). Younger patients who underwent bypass surgery showed a lower risk of the primary outcome (log-rank P=0.001) than older patients. Patients who underwent EC-IC bypass surgery had a lower risk than patients with medical therapy alone in the younger group (3.2% versus 11.6%; hazard ratio, 0.255 [95% CI, 0.071-0.916]; P=0.036), but not in the older group (17.5% versus 13.3%; adjusted hazard ratio, 0.597 [95% CI, 0.225-1.580]; P=0.298). CONCLUSIONS: In patients aged 55.5 years or younger with symptomatic atherosclerotic occlusion of the internal carotid artery or middle cerebral artery and hemodynamic insufficiency, the addition of EC-IC bypass surgery to medical therapy significantly improved prognosis. These findings suggest that the clinical application of EC-IC bypass surgery needs more research to explore refined patient selection criteria incorporating more clinical features. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01758614.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Li X, Li Y, Wang T, et al. Determining the Optimal Age for Extracranial-Intracranial Bypass Surgery: A Post Hoc Analysis of the CMOSS Randomized Trial. Stroke. 2024. PMID: 39727027. doi:10.1161/STROKEAHA.124.048766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。